GlassScriptPhysician profile
Victor John Hirsch
NPI 1720089931
$1,435.49
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $49.11 · 2022: $478 · 2023: $446 · 2024: $39.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.92 |
| Education | $104.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $385.30 | 2019-2024 | |
| Janssen Biotech, INC. | $109.93 | 2019-2023 | Darzalex, Imbruvica, Erleada |
| Novartis Pharmaceuticals Corporation | $107.54 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $78.87 | 2019-2022 | |
| Genentech USA, INC. | $74.29 | 2019-2020 | |
| Amgen INC. | $69.21 | 2022-2023 | Vectibix, Nplate, Xgeva |
| Seagen INC. | $64.99 | 2023 | |
| Eisai INC. | $61.70 | 2022-2023 | |
| Celgene Corporation | $60.62 | 2022-2023 | Reblozyl |
| Puma Biotechnology, INC. | $56.88 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.49 | 2022-2023 | |
| Kite Pharma, INC. | $52.92 | 2023 | |
| Mirati Therapeutics, INC. | $52.50 | 2023 | Krazati |
| Merck Sharp & Dohme LLC | $48.25 | 2019-2023 | Keytruda |
| Genzyme Corporation | $34.06 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $25.77 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $22.37 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.73 | 2020 | |
| Eusa Pharma (US) LLC | $15.41 | 2022 | |
| Astellas Pharma US INC | $14.79 | 2022 | |
| Daiichi Sankyo INC. | $14.49 | 2023 | Enhertu |
| Verastem, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.